Announcement

Collapse
No announcement yet.

Welcome to our forum! Before posting your questions, please read the following terms:

  1. 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
  2. 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
  3. 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
  4. 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.

By posting to the forums, you acknowledge and agree to these terms.

The InfantRisk team

Antipsychotics and breastfeeding

Collapse
X
Collapse
 
  • Page of 1
  • Filter
  • Time
  • Show
Clear All
new posts
Previous template Next
  • #1

    Antipsychotics and breastfeeding

    Is there any information about the affects of antipsychotics on breast feeding?
    Tags: None
  • #2
    Antipsychotics and breastfeeding

    Dear fwestley,
    There is some limited data on the transfer of the antipsychotics into human milk. Any one in particular you want to know about?
    Maria Milla, MD
    InfantRisk Center

    Comment

    • #3
      is there any reasearch on lamatial or depakote?

      Comment

      • #4
        Jemmie:

        I suggest you call the InfantRisk center. There is no way we can adequately evaluate your question with such limited data. 806-352-2519

        Tom Hale PH.D.

        Comment

        • #5
          I have been unable to find information on Latuda (Lurasidone). Can you give me any info on this for a patient that is currently pregnant and would like to breastfeed?

          Comment

          • #6
            Dear Elizabeth,

            Lurasidone is an atypical antipsychotic agent used in the treatment of schizophrenia. We do not have human breastmilk studies as yet on lurasidone. The drug is known to be secreted in rat milk. The molecular weight is 529 Da. The T max is 1 to 3 hours and the T 1/2 is 18 hours. Lurasidone does have high protein binding (99 %) and low oral bioavailability (9 % to 19 %) so it is not likely to enter breastmilk in clinically relevant amounts, but until we have data caution is recommended. Lurasidone is known to cause hyperglycemia and hyperprolactinemia. Other side effects of medications in this class include dyslipidemia, orthostatic hypotension, tachycardia or bradycardia, leukopenia, neutropenia and agranulocytosis, cognitive and motor impairment. The adult dose is 40 to 80 mg once daily and should be taken with food.

            Sincerely,
            Cindy Pride, MSN, CPNP
            TTUHSC InfantRisk Center

            Comment

            Previous template Next
            Working...
            X